Atlas FDA

Hemashield Vantage Vascular Graft. Vascular graft prosthesis.

FDA device recall Z-1459-05 · posted 2005-09-28 · Terminated

Recall details

Recalling firm
Boston Scientific Corporation
Reason for recall
During surgery, several reports of the grafts fraying and tearing upon suturing by the surgeon.
Action taken
Recall notifications were sent out to all customers on 6/27/2005. Enclosed within the recall notification letters are Dear Doctor Letters with directions to the customers to supplyh a copy of it to each physician who has implanted the Hemashield Vantage Vascular Graft.
Root cause
Other
Status
Terminated
Product code
DSY
Quantity affected
3487 devices
Distribution
The devices were distributed to 375 customers in the US, Argentina, Australia, Belgium, China, Colombia, Czech Republic, Germany, Denmark, Spain, France, Great Britain, Italy, Kuwait, Lebanon, Mexico,
Date initiated
2005-06-27
Date posted
2005-09-28
Date terminated
2006-08-21
Location
Natick, MA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
HEMASHIELD VANTAGE (VASCULAR GRAFT (K961847)Meadox Medicals, Div. Boston Scientific Corp.1997-01-22